Pfizer, Inc. (PFE) Tops Q3 EPS by 7c; Raises Buyback Target to $7-$9B; Reaffirms Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.27 -1.31%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.62, $0.07 better than the analyst estimate of $0.55. Revenue for the quarter came in at $17.2 billion versus the consensus estimate of $16.43 billion.
Raises its buyback target to $7-$9 billion.
Reaffirms FY11 guidance.
Raises its buyback target to $7-$9 billion.
Reaffirms FY11 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
- Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
